Bionano Genomics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bionano Genomics, Inc. (BNGO) on February 19, 2021, reporting an event that occurred on February 15, 2021. The Company is an emerging growth company incorporated in Delaware with principal executive offices in San Diego, California.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on a material definitive agreement regarding real estate.
Material Changes and Agreements
On February 15, 2021, the Company entered into a Fourth Amendment to its Lease Agreement with Irvine Eastgate Office I LLC. Key terms include:
- Expansion Space: Lease of 16,607 additional square feet of office, manufacturing, and warehousing space at 9640 Towne Center Drive, San Diego, CA.
- Lease Term: Commences February 22, 2021, and expires December 31, 2025.
- Base Rent Schedule:
- 2021 (Feb-Dec): $44,008.55 per month
- 2022: $46,001.39 per month
- 2023: $47,994.23 per month
- 2024: $50,153.14 per month
- 2025: $52,478.12 per month
- Rent Abatement: The Company is entitled to a total abatement of $176,034.20, covering four full calendar months (the 2nd, 3rd, 4th, and 5th months of the term).
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial outlook, or discussion of risks and contingencies beyond the standard qualification that the summary is not complete and refers to the full Lease Amendment exhibit.
Investor Verification Checklist
- Verify the impact of the new lease obligations on the Company's future operating expenses and cash flow requirements.
- Confirm the strategic necessity of the 16,607 square feet of additional manufacturing and warehousing space relative to current production capacity.
- Review the full text of the Fourth Amendment to Lease Agreement (to be filed as an exhibit to the 2020 Form 10-K) for additional covenants or termination rights not summarized here.